Skip to content

Therapeutic effecacy of tDCS on motor cortex combined with routine SLT in post-stroke aphasia: compared with intensive SLT

Therapeutic effecacy of tDCS on motor cortex combined with routine SLT in post-stroke aphasia: compared with intensive SLT

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019503
Enrollment
Unknown
Registered
2018-11-15
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Aphasia

Interventions

Intensive therapy group:3 weeks of intensive speech and language therapy.
Combined therapy group:3 weeks of tDCS over left primary motor cortex with routine speech and language therapy.

Sponsors

Shanghai Ninth People‘s Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Right-handed; 3. Chinese as first language; 4. Primary school or higher education; 5. Aphasia due to stroke (Aphasia Quotient of Western Aphasia Battery<93.8); 6. 3 weeks to 1 year post stroke onset; 7. A single infarction or haemorrhage in the left hemisphere confirmed by CT or MRI; 8. Written informed consent singed.

Exclusion criteria

Exclusion criteria: 1. Consciousness disorder; 2. Severe medical or psychiatric conditions; 3. Apraxia of speech or buccofacial apraxia; 4. Modified Rankin Score >4; 5. Severe cognitive impairment (MMSE <10); 6. With cardiac pacemaker, implanted stimulator or metal implant in the brain; 7. With a history of seizure or epilepsy hinted by EEG; 8. With severe vision or hearing impairments and uncooperative with speech evaluation; 9. With severely impaired auditory-verbal comprehension and unable to follow simple instructions; 10. With a history of alcohol or drug abuse; 11. On antidepressant or antipsychotic medication; 12. Women who are pregnant or in lactation period.

Design outcomes

Primary

MeasureTime frame
change in AQ of WAB from baseline to immediately after 3 weeks of treatment;

Secondary

MeasureTime frame
change in AQ of WAB from baseline to 3 months later;changes in scores of I-IV part of WAB ;change in BDAE;change in CADL;change in CETI;change in language network by functional MRI;

Countries

China

Contacts

Public ContactJian-Ren Liu

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

liujr021@sjtu.edu.cn+86 021-23271699-5597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026